Intensive 7-day Treatment for PTSD Combining Ketamine With Exposure Therapy (PTSD)
Diseases of the Nervous System | Mental Health & Behavioral Research
What is the purpose of this trial?
The purpose of this study is to combine a single infusion of Ketamine with 7-days of trauma focus psychotherapy to relieve post traumatic stress disorder (PTSD) symptoms more effectively. This treatment has the potential to produce a significant therapeutic effect that otherwise would take months to occur.
- Ages21 years - 70 years
- Trial withYale University School of Medicine
- Start Date03/10/2016
- End Date11/01/2018
- Last Updated07/15/2021
- Study HIC#1509016530